Transplantation and innate immunity: The lesson of natural killer cells

Italian Journal of Pediatrics

Volumn 35, Issue 44, 2009, Pages

  Bertaina, Alice ^a   Locatelli, Franco ^a   Moretta, Lorenzo ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEUKEMIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGRAFT; ANTINEOPLASTIC ACTIVITY; CHILDHOOD LEUKEMIA; HAPLOIDY; HLA SYSTEM; HUMAN; INNATE IMMUNITY; NATURAL KILLER CELL; NONHUMAN; ORGAN DONOR; RECIPIENT; REVIEW; T CELL DEPLETION;

EID: 74949099719     PISSN: 17208424     EISSN: 18247288     Source Type: Journal    
DOI: 10.1186/1824-7288-35-44     Document Type: Review

References (20)

1. Copelan EA: Hematopoietic stem cell transplantation. N Engl J Med 2006, 354:1813-1826.
2. Locatelli F, Burgio GR: Transplant of haematopoietic stem cells in childhood: where we are and where we are going. Haematologica 1998, 83:550-563.
3. Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA: Immunological reconstitution of sex linked lymphopenic immunological deficiency. Lancet 1968, 2:1366-1369.
4. Bach FM, Albertini MJ, Joho P, Anderson JL, Bortin MM: Bone marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet 1968, 2:1364-1366.
5. Moretta L, Locatelli F, Moretta A: Human NK cells: from HLA class I-specific Ig-like receptors to the therapy of acute leukemias. Immunol Rev 2008, 224:58-69.
6. Rocha V, Locatelli F: Searching for alternative hematopoietic stem cell donors for pediatric patients. Bone Marrow Transplant 2008, 41:207-214.
7. Bachar-Lustig E, Rachamim N, Li HW, Lan F, Reisner Y: Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nat Med 1995, 1:1268-1273.
8. Aversa F, Tabilio A, Velardi A, Cunningham I, Terenzi A, Falzetti F, Ruggeri L, Barbabietola G, Aristei C, Latini P, Reisner Y, Martelli MF: Treatment of high risk acute leukaemia with T-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Eng J of Med 1998, 339:1186-1193.
9. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, et al.: Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002, 295:2097-2100.
10. Caligiuri M: Human natural killer cells. Blood 2008, 112:461-69.
11. Locatelli F, Pende D, Maccario R, Mingari MC, Moretta A, Moretta L: Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: How NK cells make the difference. Clin Immunol 2009, 133:171-8.
12. Pende D, Marcenaro S, Falco M, Martini S, Bernardo ME, Montagna D, Romeo E, Cognet C, Martinetti M, Maccario R, Mingari MC, Vivier E, Moretta L, Locatelli F, Moretta A: Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and re-definition of inhibitory KIR specificity. Blood 2009, 113:3119-3129.
13. Ljunggren HG, Karre K: In search of the "missing self". MHC molecules and NK cell recognition. Immunol Today 1990, 11:237-244.
14. Bennet M: Biology and genetics of hybrid resistance. Adv: Immunol 1987, 41:333-445.
15. Aversa F, Terenzi A, Tabilio A, Falzetti F, Carotti A, Ballanti S, Felicini R, Falcinelli F, Velardi A, Ruggeri L, Aloisi T, Saab JP, Santucci A, Perruccio K, Martelli MP, Mecucci C, Reisner Y, Martelli MF: Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol 2005, 23:3447-3454.
16. Bottino C, Castriconi R, Moretta L, Moretta A: Cellular ligands for activating NK receptors. Trends Immunol 2005, 26:221-226.
17. Moretta L, Bottino C, Pende D, Vitale M, Mingari MC, Moretta A: Different checkpoints in human NK-cell activation. Trends in Immunol 2004, 25:670-76.
18. Pende D, Spaggiari GM, Marcenaro S, Martini S, Rivera P, Capobianco A, Falco M, Lanino E, Pierri I, Zambello R, Bacigalupo A, Mingari MC, Moretta A, Moretta L: Analysis of the receptor-ligand interactions in the NK-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias. Evidence for the involvement of the poliovirus receptor (CD155) and Nectin-2 (CD112). Blood 2005, 105:2066-2073.
19. Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J, Shlomchik MJ, Emerson SG: Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999, 285:412-15.
20. Stern M, Ruggeri L, Mancusi A, Bernardo ME, De Angelis C, Bucher C, Locatelli F, Aversa F, Velardi A: Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. Blood 2008, 112:2990-2995.